Browsing Pharmacy Research by Subject "Curcumin"
Now showing items 1-6 of 6
-
Cetuximab-conjugated chitosan-pectinate (modified) composite nanoparticles for targeting colon cancer
( Elsevier B.V. , 2019 , Article)In the present study, we successfully developed a cetuximab-conjugated modified citrus pectin-chitosan nanoparticles for targeted delivery of curcumin (Cet-MCPCNPs) for the treatment of colorectal cancer. In vitro analyses ... -
Characterization and ex vivo evaluation of curcumin nanoethosomes for melanoma treatment
( Taylor & Francis , 2022 , Article)This study aimed at developing curcumin nanoethosomes (Cur-Ets) with superior skin permeation intended for melanoma treatment. Although curcumin is active against many types of skin cancers, a suitable topical formulation ... -
Is curcumin at the threshold of therapeutic effectiveness on patients with colon cancer? – A systematic review
( Qatar University Press , 2021 , Poster)Curcumin, obtained from Curcuma longa, has been the subject of decades of scientific investigation on its therapeutic usefulness. It is reported to possess several therapeutic properties, of which anti-colon cancer is of ... -
A novel approach of encapsulating curcumin and succinylated derivative in mannosylated-chitosan nanoparticles
( Elsevier , 2022 , Article)Curcumin (CUR) manifests anti-colon cancer activity but suffers from low solubility, bioavailability, and instability, rendering it not as effective as its chemotherapeutic cousins. Here, we conjugate CUR to succinic ... -
Prospects of Curcumin Nanoformulations in Cancer Management
( Multidisciplinary Digital Publishing Institute (MDPI) , 2022 , Article)There is increasing interest in the use of natural compounds with beneficial pharmacological effects for managing diseases. Curcumin (CUR) is a phytochemical that is reportedly effective against some cancers through its ... -
Studies on anti-colon cancer potential of nanoformulations of curcumin and succinylated curcumin in mannosylated chitosan
( Elsevier , 2023 , Article)Colon cancer (CRC) is the second leading cause of death and the third most diagnosed cancer worldwide. Although curcumin (CUR) has demonstrated a potent anticancer activity, it is characterized by its poor solubility, low ...